ABC News: FDA Approves Study of Scorpion-Derived ‘Tumor Paint’ for Brain Cancer Patients

| Posted in Brain Injury, Brain Research

Seattle cancer researchers are hoping that they will be able to use scorpion venom to fight deadly brain cancer through a new product called “Tumor Paint.” For the first time, the Food and Drug Administration has approved the product, developed by Blaze Bioscience, for study in human trials in the U.S. During the phase one trial, the tumor paint will be used to on an estimated 21 people with a glioma, or tumor in the brain or spine. (September 27, 2014)

Read the full article here